Page last updated: 2024-10-26

dipyridamole and Granulomatosis with Polyangiitis

dipyridamole has been researched along with Granulomatosis with Polyangiitis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaushal, R1
Dash, SC1
Kapur, S1
Bhuyan, UN1

Other Studies

1 other study available for dipyridamole and Granulomatosis with Polyangiitis

ArticleYear
Wegener's granulomatosis with rapidly progressive glomerulonephritis.
    The Journal of the Association of Physicians of India, 1987, Volume: 35, Issue:5

    Topics: Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis; Granulomatosis

1987